Mitochondrial Ca2+ signaling: A metabolic rheostat defining tumor and immune cell fate
Trends in Immunology · 2026-06
DOI: 10.1016/j.it.2026.05.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2026-06. Verfasst von Amélie E Bura und 3 weiteren Autor:innen. Beteiligte Einrichtung: INSERM UMR1069 N2Cox Niche Nutrition, Cancer Et Métabolisme Oxydatif, Tours, France. Die Arbeit nennt 121 Literaturangaben. Gefördert von: Le Studium Loire Valley-Institute for Advanced Studies, Region Centre-Val de Loire, Cancéropôle du Grand Ouest.
Abstract (Originalsprache)
Mitochondrial calcium (mtCa2+) has long been framed as a bioenergetic regulator, yet evidence redefines it as a relevant immunometabolic switch. Within the tumor microenvironment, the mitochondrial calcium uniporter (MCU) complex and the NCLX-TMEM65 efflux axis maintain a 'Goldilocks zone' of Ca2+ homeostasis. This can be exploited by cancer cells to sustain oxidative phosphorylation and tricarboxylic acid-derived oncometabolite production, including succinate, fumarate, and 2-hydroxyglutarate, while imposing ionic and nutrient constraints on infiltrating immune cells. Chronic mtCa2+ overload in effector T cells drives mitochondrial dysfunction and exhaustion, while oxidative phosphorylation-dependent Ca2+ flux enforces the acquisition of an immunosuppressive profile in macrophages. Disrupting these tumor-immune ionic imbalances through selective MCU modulation or efflux pathway targeting offers a strategy to restore immune surveillance and/or enhance immune checkpoint inhibitor therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- INSERM UMR1069 N2Cox Niche Nutrition, Cancer Et Métabolisme Oxydatif, Tours, France.
- INSERM UMR1100 CEPR Centre d'Etude Des Pathologies Respiratoires, Tours, France.
- INSERM UMR1069 N2Cox Niche Nutrition, Cancer Et Métabolisme Oxydatif, Tours, France. Electronic address: maxime.gueguinou@univ-tours.fr.
Förderung
- Le Studium Loire Valley-Institute for Advanced Studies
- Region Centre-Val de Loire
- Cancéropôle du Grand Ouest
- National League Against Cancer
- Fondation ARC pour la Recherche sur Le Cancer
Zitieren
APA
Bura, A. E., Rolong, A., Paget, C., & Guéguinou, M. (2026). Mitochondrial Ca2+ signaling: A metabolic rheostat defining tumor and immune cell fate. Trends in Immunology. https://doi.org/10.1016/j.it.2026.05.012
Vancouver
Bura AE, Rolong A, Paget C, Guéguinou M. Mitochondrial Ca2+ signaling: A metabolic rheostat defining tumor and immune cell fate. Trends in Immunology. 2026. doi:10.1016/j.it.2026.05.012
BibTeX
@article{Bura2026,
author = {Bura, Amélie E and Rolong, Andrea and Paget, Christophe and Guéguinou, Maxime},
title = {Mitochondrial Ca2+ signaling: A metabolic rheostat defining tumor and immune cell fate},
journal = {Trends in Immunology},
year = {2026},
doi = {10.1016/j.it.2026.05.012}
}
EUVIMED